Zelapar is a prescription drug commonly used to treat Parkinson's disease. This selection from the eMedTV Web site provides an overview of Zelapar, including information on how this medication works, possible side effects, dosing tips, and more.
Nausea, dizziness, and headaches are among the most common side effects reported with Zelapar. This eMedTV page lists other Zelapar side effects, including serious side effects (such as hallucinations and depression) that require prompt medical care.
Zelapar is used for relieving symptoms of Parkinson's disease. This eMedTV segment takes an in-depth look at Zelapar uses, including information on how this medication can increase dopamine levels in the brain and possible off-label uses.
As this eMedTV page explains, Zelapar dosing guidelines vary for each person, depending on how you respond to the drug and other factors. This page offers other dosing tips and explains that the typical starting Zelapar dosage is 1.25 mg once daily.
Zelapar can interact with several medicines, possibly increasing the risk of dangerous side effects. This eMedTV Web page takes an in-depth look at several Zelapar drug interactions and describes the complications that these interactions may cause.
This eMedTV segment explains that in order to avoid serious and even life-threatening problems, make sure to review Zelapar warnings and precautions with your doctor before taking the drug. This page also explains who should not use this medication.
Seek immediate medical care if you have overdosed on Zelapar (orally disintegrating selegiline). This page of the eMedTV library outlines the potential symptoms of a Zelapar overdose and describes possible treatment options that are available.
As this eMedTV Web article explains, animal studies indicate that Zelapar (orally disintegrating selegiline) may not be safe for use during pregnancy. This page further discusses Zelapar and pregnancy, and describes the problems that may occur.
This eMedTV resource explains that no studies have been done to see if Zelapar (orally disintegrating selegiline) passes through breast milk. This article also describes what to do if you are taking Zelapar and breastfeeding or plan to breastfeed.
There are currently no approved generic forms of Zelapar (orally disintegrating selegiline). This eMedTV page covers why there is no generic Zelapar and explains that July 2014 is the earliest date that a generic version could become available.
| Referring Pages | Articles |
